Studies found that the trends of apoB and LDL-C differs in more than one quarter of people, especially in people with metabolic risk factors (such as obesity or type 2 diabetes) (22) and those taking statins (23). This evidence concerns the gene APOB and obesity due to melanocortin 4 receptor deficiency.